149 related articles for article (PubMed ID: 8740303)
1. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children.
Seidel H; Nygaard R; Haave I; Moe PJ
Acta Paediatr; 1996 Apr; 85(4):450-3. PubMed ID: 8740303
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate.
Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H
Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
Vainionpää L; Kovala T; Tolonen U; Lanning M
Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
[TBL] [Abstract][Full Text] [Related]
4. A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.
Reddick WE; Glass JO; Helton KJ; Langston JW; Li CS; Pui CH
AJNR Am J Neuroradiol; 2005 Oct; 26(9):2371-7. PubMed ID: 16219848
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal methotrexate overdose.
Lee AC; Wong KW; Fong KW; So KT
Acta Paediatr; 1997 Apr; 86(4):434-7. PubMed ID: 9174236
[TBL] [Abstract][Full Text] [Related]
6. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.
Pääkkö E; Harila-Saari A; Vanionpää L; Himanen S; Pyhtinen J; Lanning M
Med Pediatr Oncol; 2000 Nov; 35(5):456-61. PubMed ID: 11070477
[TBL] [Abstract][Full Text] [Related]
7. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
[TBL] [Abstract][Full Text] [Related]
8. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
[TBL] [Abstract][Full Text] [Related]
9. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
10. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
[TBL] [Abstract][Full Text] [Related]
11. Brain perfusion after treatment of childhood acute lymphoblastic leukemia.
Harila-Saari AH; Ahonen AK; Vainionpää LK; Pääkkö EL; Pyhtinen J; Himanen AS; Torniainen PJ; Lanning BM
J Nucl Med; 1997 Jan; 38(1):82-8. PubMed ID: 8998157
[TBL] [Abstract][Full Text] [Related]
12. Long-term cerebral effects of CNS chemotherapy in children with acute lymphoblastic leukemia.
Bakke SJ; Fossen A; Storm-Mathiesen I; Lie SO
Pediatr Hematol Oncol; 1993; 10(3):267-70. PubMed ID: 8217544
[TBL] [Abstract][Full Text] [Related]
13. Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate.
Glass JO; Reddick WE; Li CS; Laningham FH; Helton KJ; Pui CH
Magn Reson Imaging; 2006 Jul; 24(6):785-91. PubMed ID: 16824973
[TBL] [Abstract][Full Text] [Related]
14. Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.
Pande AR; Ando K; Ishikura R; Nagami Y; Ogawa M; Kamikonya N; Kaneda Y; Tanizawa T; Nakao N
Radiat Med; 2006 Aug; 24(7):515-9. PubMed ID: 17058146
[TBL] [Abstract][Full Text] [Related]
15. Brain white matter changes during treatment of a child for acute lymphoblastic leukemia.
Maeda M; Hayakawa J; Ueda T; Migita M; Asano T; Fukunaga Y; Amano Y
J Nippon Med Sch; 2005 Oct; 72(5):252-3. PubMed ID: 16247223
[TBL] [Abstract][Full Text] [Related]
16. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
[TBL] [Abstract][Full Text] [Related]
17. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N
J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676
[TBL] [Abstract][Full Text] [Related]
18. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia.
Rubnitz JE; Relling MV; Harrison PL; Sandlund JT; Ribeiro RC; Rivera GK; Thompson SJ; Evans WE; Pui CH
Leukemia; 1998 Aug; 12(8):1176-81. PubMed ID: 9697870
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system prophylaxis with high-dose methotrexate does not give rise to significant electroencephalographic changes in children with acute lymphoblastic leukemia.
Korinthenberg R; Schneider A; Niemeyer C
J Child Neurol; 2002 Jun; 17(6):409-12. PubMed ID: 12174959
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate in childhood all.
Moe PJ; Holen A
Pediatr Hematol Oncol; 2000 Dec; 17(8):615-22. PubMed ID: 11127393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
